![Douglas C. Bates](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Douglas C. Bates
Fondateur chez Cyprotex US LLC
Provenance du réseau au premier degré de Douglas C. Bates
Entité | Type d'entité | Industrie | |
---|---|---|---|
Subsidiary | Miscellaneous Commercial Services | 2 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Douglas C. Bates via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
MMC Ventures Ltd.
![]() MMC Ventures Ltd. Investment ManagersFinance MMC Ventures Ltd.(MMC Ventures) is a venture capital firm founded in 2000 by Bruce Ferguson MacFarlane and Alan William Morgan. The firm is headquartered in London. | Investment Managers | Director of Investments | |
IPGL Ltd.
![]() IPGL Ltd. Investment ManagersFinance IPGL Ltd (IPGL) is a private equity firm founded in 1986. The firm is headquartered in London. | Investment Managers | Director of Investments | |
Sheffield Haworth Ltd.
![]() Sheffield Haworth Ltd. Personnel ServicesCommercial Services Sheffield Haworth Ltd. engages in the provision of recruitment services. It offers executive search, human capital research and advisory, and performance consulting services. The company was founded by Timothy Sheffield, Nigel Haworth and Patrick Morrissey in 1993 and is headquartered in London, the United Kingdom. | Personnel Services | Director/Board Member | |
DDCAP Ltd.
![]() DDCAP Ltd. Financial ConglomeratesFinance DDCAP Ltd. provides intermediary services to both conventional and Islamic financial market participants. Its services include liquidity management, syndicated financing, fund management, structured transactions, structures trade financing, and capital markets. The company was founded in 1998 and is headquartered in London, the United Kingdom. | Financial Conglomerates | Director/Board Member | |
CG Asset Management Ltd.
![]() CG Asset Management Ltd. Investment ManagersFinance CG Asset Management Ltd. (CGAM) is an independent, Great Britain-based fund manager which was founded in 2000. Headquartered in London, CGAM provides investment advice to institutional and professional clients. | Investment Managers | Chief Investment Officer | |
CAPITAL GEARING TRUST P.L.C | Investment Trusts/Mutual Funds | Chief Tech/Sci/R&D Officer | |
New College Oxford | College/University | Undergraduate Degree | |
Tufts University | College/University | Doctorate Degree | |
Cyprotex US LLC
![]() Cyprotex US LLC Miscellaneous Commercial ServicesCommercial Services Part of Evotec SE, Cyprotex US LLC is a company that provides contract research services specializing in preclinical ADME and Toxicology assessment. The company is based in Watertown, MA. Cyprotex US was acquired by Cyprotex Ltd., part of Evotec SE from December 15, 2016 on August 06, 2010 for $4.22 million. The company was founded by Douglas C. Bates, Katherine Tsaioun. | Miscellaneous Commercial Services | Founder | |
BioTek Instruments LLC
![]() BioTek Instruments LLC Medical SpecialtiesHealth Technology BioTek Instruments LLC provides microplate instrumentation and software for the drug discovery, genomics and proteomics and life science research fields. Its products include automated microplate detection systems for absorbance, fluorescence and chemiluminescence measurements, along with a complete line of automated washers, dispensers and pipetting systems, microplate stackers and robots, and data analysis software. BioTek Instruments was founded by Norman Alpert in 1968 and id headquartered in Winooski, VT. | Medical Specialties | Founder | |
Alzheimers Drug Discovery Foundation
![]() Alzheimers Drug Discovery Foundation BiotechnologyHealth Technology The Alzheimer's Drug Discovery Foundation (ADDF) is a public charity founded in 1998 by Ronald Steven Lauder, Leonard Alan Lauder, and Howard Fillit. The non-profit company is based in New York, NY. The ADDF is dedicated to accelerating the discovery of drugs to prevent, treat, and cure Alzheimer's disease. The company is the only public charity solely focused on funding the development of drugs for Alzheimer's, using a venture philanthropy model to support research in academia and the biotech industry. The ADDF has awarded over $209 million to fund over 690 Alzheimer's drug discovery programs, biomarker programs, and clinical trials in 19 countries. The CEO is Mark Roithmayr. | Biotechnology | Corporate Officer/Principal |
Statistiques
Internationale
Royaume-Uni | 8 |
Etats-Unis | 5 |
Sectorielle
Finance | 5 |
Commercial Services | 3 |
Consumer Services | 3 |
Health Technology | 3 |
Miscellaneous | 2 |
Opérationnelle
Director/Board Member | 4 |
Director of Investments | 2 |
Director of Finance/CFO | 2 |
Chief Tech/Sci/R&D Officer | 2 |
Founder | 2 |
Relations les plus connectées
Insiders | |
---|---|
Chris Clothier | 8 |
Katherine Tsaioun | 5 |
- Bourse
- Insiders
- Douglas C. Bates
- Connexions Sociétés